190 related articles for article (PubMed ID: 38188680)
21. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-
Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z
Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625
[TBL] [Abstract][Full Text] [Related]
22. Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells.
Vadgama JV; Wu Y; Shen D; Hsia S; Block J
Anticancer Res; 2000; 20(3A):1391-414. PubMed ID: 10928049
[TBL] [Abstract][Full Text] [Related]
23. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
[TBL] [Abstract][Full Text] [Related]
24. Selenium effects on prostate cell growth.
Menter DG; Sabichi AL; Lippman SM
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1171-82. PubMed ID: 11097224
[TBL] [Abstract][Full Text] [Related]
25. Glutamate-urea-based PSMA-targeted PLGA nanoparticles for prostate cancer delivery of docetaxel.
Saniee F; Shabani Ravari N; Goodarzi N; Amini M; Atyabi F; Saeedian Moghadam E; Dinarvand R
Pharm Dev Technol; 2021 Apr; 26(4):381-389. PubMed ID: 33538232
[TBL] [Abstract][Full Text] [Related]
26. Enhanced in vitro DNA transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancer.
Hattori Y; Maitani Y
J Control Release; 2004 May; 97(1):173-83. PubMed ID: 15147814
[TBL] [Abstract][Full Text] [Related]
27. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
[TBL] [Abstract][Full Text] [Related]
28. Increasing the colon cancer cells sensitivity toward radiation therapy via application of Oct4-Sox2 complex decoy oligodeoxynucleotides.
Johari B; Rezaeejam H; Moradi M; Taghipour Z; Saltanatpour Z; Mortazavi Y; Nasehi L
Mol Biol Rep; 2020 Sep; 47(9):6793-6805. PubMed ID: 32865703
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, characterization and antitumor properties of selenium nanoparticles coupling with ferulic acid.
Cui D; Yan C; Miao J; Zhang X; Chen J; Sun L; Meng L; Liang T; Li Q
Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():104-112. PubMed ID: 29853073
[TBL] [Abstract][Full Text] [Related]
30. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides.
Eder IE; Culig Z; Ramoner R; Thurnher M; Putz T; Nessler-Menardi C; Tiefenthaler M; Bartsch G; Klocker H
Cancer Gene Ther; 2000 Jul; 7(7):997-1007. PubMed ID: 10917202
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of selenium on benign and malignant prostate epithelial cells: stimulation of LNCaP cell growth by noncytotoxic, low selenite concentrations.
Kandaş NO; Randolph C; Bosland MC
Nutr Cancer; 2009; 61(2):251-64. PubMed ID: 19235042
[TBL] [Abstract][Full Text] [Related]
33. Gamma rays-assisted bacterial synthesis of bimetallic silver-selenium nanoparticles: powerful antimicrobial, antibiofilm, antioxidant, and photocatalytic activities.
El-Behery RR; El-Sayed ER; El-Sayyad GS
BMC Microbiol; 2023 Aug; 23(1):224. PubMed ID: 37587432
[TBL] [Abstract][Full Text] [Related]
34. Suppressing the metastatic properties of the breast cancer cells using STAT3 decoy oligodeoxynucleotides: A promising approach for eradication of cancer cells by differentiation therapy.
Rahmati M; Johari B; Kadivar M; Rismani E; Mortazavi Y
J Cell Physiol; 2020 Jun; 235(6):5429-5444. PubMed ID: 31912904
[TBL] [Abstract][Full Text] [Related]
35. Multifunctional nanoparticles from albumin for stimuli-responsive efficient dual drug delivery.
Nosrati H; Abhari F; Charmi J; Davaran S; Danafar H
Bioorg Chem; 2019 Jul; 88():102959. PubMed ID: 31075743
[TBL] [Abstract][Full Text] [Related]
36. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
[TBL] [Abstract][Full Text] [Related]
37. Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio.
Reagan-Shaw S; Nihal M; Ahsan H; Mukhtar H; Ahmad N
Prostate; 2008 Nov; 68(15):1624-34. PubMed ID: 18668529
[TBL] [Abstract][Full Text] [Related]
38. Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells.
Tambe P; Kumar P; Paknikar KM; Gajbhiye V
Int J Nanomedicine; 2018; 13():7669-7680. PubMed ID: 30538451
[TBL] [Abstract][Full Text] [Related]
39. In vitro cytotoxicity, macromolecular interaction and antioxidant potential of dual coated selenium nanoparticles.
Shinde V; Desai K
J Biomed Mater Res B Appl Biomater; 2022 Jun; 110(6):1400-1411. PubMed ID: 34997682
[TBL] [Abstract][Full Text] [Related]
40. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
